1. Targeting lung cancer through inhibition of checkpoint kinases
   Randi G. Syljuåsen et al, 2015, Front. Genet. CrossRef
2. HIF-1α inhibition sensitizes pituitary adenoma cells to temozolomide by regulating MGMT expression
   WENNA CHEN et al, 2013 CrossRef
3. CD133+ cells contribute to radioresistance via altered regulation of DNA repair genes in human lung cancer cells
   Amar Desai et al, 2014, Radiotherapy and Oncology CrossRef
4. Silencing of the long non-coding RNA NEAT1 suppresses glioma stem-like properties through modulation of the miR-107/CDK6 pathway
   Xiaoli Yang et al, 2017 CrossRef
5. Claspin functions in cell homeostasis—A link to cancer?
   Diana Azenha et al, 2017, DNA Repair CrossRef
6. Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer Patients
   Henry Okuchukwu Ebili et al, 2017, Mol Diagn Ther CrossRef
7. A novel Chk1-binding peptide that enhances genotoxic sensitivity through the cellular redistribution of nuclear Chk1
   Kwang Seok Kim et al, 2016 CrossRef
8. 5-FU resistance abrogates the amplified cytotoxic effects induced by inhibiting checkpoint kinase 1 in p53-mutated colon cancer cells
   TOMOFUMI AKASAKA et al, 2015 CrossRef
9. Disulfiram sensitizes pituitary adenoma cells to temozolomide by regulating O6-methylguanine-DNA methyltransferase expression
   YACHAO ZHAO et al, 2015 CrossRef
10. Molecularly Targeted Agents as Radiosensitizers in Cancer Therapy—Focus on Prostate Cancer
    Sara Alcorn et al, 2013, IJMS CrossRef
11. Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers
    Gang Zhou et al, 2018, Advanced Drug Delivery Reviews CrossRef
12. Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancer
    Nouf Alsubhi et al, 2016 CrossRef
13. Sensitization of prostate cancer to radiation therapy: Molecules and pathways to target
    Mu Yao et al, 2018, Radiotherapy and Oncology CrossRef
14. Role of Environmental Chemicals, Processed Food Derivatives, and Nutrients in the Induction of Carcinogenesis
    Luca Persano et al, 2015, Stem Cells and Development CrossRef
15. Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems
    Hassan Dianat-Moghadam et al, 2018, Journal of Controlled Release CrossRef
16. Therapy resistance mediated by cancer stem cells
    Teresa Bernadette Steinbichler et al, 2018, Seminars in Cancer Biology CrossRef
17. null
    Diana Azenha et al, 2018 CrossRef
18. Regulation of the Intracellular ROS Level Is Critical for the Antiproliferative Effect of Quercetin in the Hepatocellular Carcinoma Cell Line HepG2
    Ji-Sook Jeon et al, 2019, Nutrition and Cancer CrossRef
19. DNA damage response and prostate cancer: defects, regulation and therapeutic implications
    S Karanika et al, 2015, Oncogene CrossRef
20. Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.
    L Chang et al, 2013, Cell Death Dis CrossRef
21. Cancer stem cells: A review from origin to therapeutic implications.
    Mohammad Reza Atashzar et al, 2020, J Cell Physiol CrossRef
22. Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells
    Nishant Gandhi et al, 2013, Cancer Biology & Therapy CrossRef
23. Roles of Chk1 in cell biology and cancer therapy.
    Youwei Zhang et al, 2014, Int. J. Cancer CrossRef
24. Isogenic radiation resistant cell lines: development and validation strategies.
    Niamh McDermott et al, 0 CrossRef
25. Interactions between Endothelial Cells and T Cells Modulate Responses to Mixed Neutron/Gamma Radiation
    Lynnette H. Cary et al, 2014, Radiation Research CrossRef
26. A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
    Monica Cojoc et al, 2015, Seminars in Cancer Biology CrossRef
27. The molecular mechanisms underlying the therapeutic resistance of cancer stem cells
    Jun-Kyum Kim et al, 2015, Arch. Pharm. Res. CrossRef
28. The miR-15 family enhances the radiosensitivity of breast cancer cells by targeting G2 checkpoints.
    Zijie Mei et al, 2015, Radiat. Res. CrossRef
29. Cellular and Molecular Mechanisms Underlying Oxygen-Dependent Radiosensitivity
    Chao Liu et al, 2015, Radiation Research CrossRef
30. Serine–Threonine Kinase 38 regulates CDC25A stability and the DNA damage-induced G2/M checkpoint
    Takemichi Fukasawa et al, 2015, Cellular Signalling CrossRef
31. Radiation resistance: Cancer stem cells (CSCs) and their enigmatic pro-survival signaling
    Ira Skvortsova et al, 2015, Seminars in Cancer Biology CrossRef
32. Dietary flavonoid derivatives enhance chemotherapeutic effect by inhibiting the DNA damage response pathway
    Ching-Ying Kuo et al, 2016, Toxicology and Applied Pharmacology CrossRef
33. Cancer stem cells and signaling pathways in radioresistance
    Lei Chang et al, 2016, Oncotarget CrossRef
34. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer
    María Auxiliadora Olivares-Urbano et al, 2020, Cells CrossRef
35. Checkpoint Kinase 1 (CHK1) Inhibition Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Proton Irradiation via Rad51 Downregulation
    Changhoon Choi et al, 2020, IJMS CrossRef
36. Targeting Radiation-Resistant Prostate Cancer Stem Cells by B7-H3 CAR T Cells.
    Yida Zhang et al, 2021, Mol Cancer Ther CrossRef
37. Epigenetic mechanisms underlying prostate cancer radioresistance.
    Catarina Macedo-Silva et al, 2021, Clin Epigenetics CrossRef
38. null
    Georgios Solomou et al, 2021 CrossRef
39. Genome-Wide Analysis of lncRNA-mRNA Co-Expression Networks in CD133+/CD44+ Stem-like PDAC Cells
    Giasemi C. Eptaminitaki et al, 2023, Cancers CrossRef
40. Molecular mechanisms of tumor resistance to radiotherapy.
    Yu Wu et al, 2023, Mol Cancer CrossRef
41. null
    Elena Arechaga-Ocampo, 2023 CrossRef
42. null
    Sana Hachem et al, 2024 CrossRef
43. Molecular mechanisms and targeted therapy for the metastasis of prostate cancer to the bones (Review)
    Yankai Xu et al, 2024, Int J Oncol CrossRef